BC Environmental and Occupational Health Research Network

JDRF is soliciting expressions of interest (EOI) for the discovery, development and pre-clinical testing of tolerogenic nanoparticle delivery systems of diabetes specific antigens designed to prevent and/or reverse type 1 diabetes (T1D). JDRF is committed to translation of research findings towards clinical results and is most interested in translationally relevant projects.